Hip joint replacement
Because the potential of high toxicity, these agents are utilized for life-threatening extra-articular manifestations or severe articular disease refractory to other therapy. hip joint replacement Causes-of-right-side-pain. It is recommended that these agents be used under the direction of a rheumatologist. Azathioprine is a purine analog that can cause severe bone marrow suppression particularly in patients with renal insufficiency or when used concomitantly with allopurinol or ACE inhibitors. Increased risk of secondary malignancy due to azathioprine is controversial. hip joint replacement Chest pains. Cyclophosphamide is an alkylating agent with serious toxicity's including bone marrow suppression, hemorrhagic cystitis, premature ovarian failure, infection and secondary malignancy particularly an increased risk of bladder cancer. For these reasons it is not used in the treatment of uncomplicated rheumatoid arthritis. Cyclophosphamide is used in rheumatoid vasculitis or lung disease. hip joint replacement Pain after root canal. Cyclosporine is an immunosuppressive agent approved for use in preventing renal and liver allograft rejection. Cyclosporine inhibits T cell function by inhibiting transcription of interleukin-2. Main toxicity's include infection and renal insufficiency. (top of section)(top of page) Treatment During Pregnancy Rheumatoid arthritis therapy during pregnancy is complicated by the fact that none of the drugs discussed above have been shown to be safe in pregnant women with adequate, controlled studies. Although joint symptoms frequently remit during pregnancy, this effect is not universal. Treatment decisions require careful consideration of the risks and benefits to the mother and fetus. All DMARD therapy should be stopped in women planning to conceive and in pregnant and lactating women. Evidence of the risks of these agents to the fetus either exists or cannot be ruled out. Methotrexate, because of evidence of potential teratogencity should be stopped in men and women planning conception (see above). Although safety has not been proven in controlled trials, no evidence exists for risks to the fetus of low dose prednisone (less than 20mg daily) or of NSAIDs used in the first two trimesters. If necessary, joint symptoms are best managed with the lowest possible dose of prednisone.
Hip joint replacement
Painacute || Rheumatoid-arthritis-foundation || Rheumatoid-arthritis-and-pregnacy || Poly-arthritis